Rhythm Pharmaceuticals, Inc. (RYTM)
NASDAQ: RYTM · Real-Time Price · USD
104.60
-1.10 (-1.04%)
At close: Dec 5, 2025, 4:00 PM EST
105.34
+0.74 (0.71%)
After-hours: Dec 5, 2025, 6:15 PM EST
Rhythm Pharmaceuticals Employees
Rhythm Pharmaceuticals had 283 employees as of December 31, 2024. The number of employees increased by 57 or 25.22% compared to the previous year.
Employees
283
Change (1Y)
57
Growth (1Y)
25.22%
Revenue / Employee
$616,021
Profits / Employee
-$698,625
Market Cap
6.98B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
RYTM News
- 10 days ago - Rhythm: Maintaining Strong Buy On Acquired Hypothalamic Obesity Drug Progress - Seeking Alpha
- 26 days ago - Rhythm Pharmaceuticals Announces Presentation of Four Datasets at ObesityWeek® 2025 - GlobeNewsWire
- 27 days ago - Rythm Pharmaceuticals' (RYTM) Chief Technical Officer Sells 9,748 Shares for $1.1 Million - The Motley Fool
- 4 weeks ago - Rhythm Pharmaceuticals Announces FDA Extension of Review Period for IMCIVREE® (setmelanotide) for Patients with Acquired Hypothalamic Obesity - GlobeNewsWire
- 4 weeks ago - Rhythm Pharmaceuticals Announces Public Reimbursement for IMCIVREE® (setmelanotide) in Canada in Five Provinces and Under the Federal Non-Insured Health Benefits Program - GlobeNewsWire
- 4 weeks ago - Rhythm Pharmaceuticals, Inc. (RYTM) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Rhythm Pharmaceuticals Reports Third Quarter 2025 Financial Results and Business Update - GlobeNewsWire
- 6 weeks ago - Rhythm Pharmaceuticals to Report Third Quarter 2025 Financial Results on Tuesday, November 4, 2025 - GlobeNewsWire